Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Round Rock, TX
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Round Rock, TX
Click here to add this to my saved trials
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Norfolk, VA
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Seattle, WA
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Tacoma, WA
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Neenah, WI
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Neenah, WI
Click here to add this to my saved trials
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Birmingham, AL
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
San Jose, CA
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
San Jose, CA
Click here to add this to my saved trials
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Port Charlotte, FL
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
St. Petersburg, FL
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated:  8/27/2015
Research Site
mi
from
Franklin, IL
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated: 8/27/2015
Research Site
mi
from
Franklin, IL
Click here to add this to my saved trials
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Centerville, OH
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Centerville, OH
Click here to add this to my saved trials
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Richmond, VA
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Bellingham, WA
Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (Dimethyl Fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Bellingham, WA
Click here to add this to my saved trials
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) on Reducing Infarct Volume in Acute Ischemic Stroke
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
San Diego, CA
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) on Reducing Infarct Volume in Acute Ischemic Stroke
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) on Reducing Infarct Volume in Acute Ischemic Stroke
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Kansas City, KA
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) on Reducing Infarct Volume in Acute Ischemic Stroke
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Kansas City, KA
Click here to add this to my saved trials
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) on Reducing Infarct Volume in Acute Ischemic Stroke
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Boston, MA
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) on Reducing Infarct Volume in Acute Ischemic Stroke
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) on Reducing Infarct Volume in Acute Ischemic Stroke
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Golden Valley, MN
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) on Reducing Infarct Volume in Acute Ischemic Stroke
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Golden Valley, MN
Click here to add this to my saved trials
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) on Reducing Infarct Volume in Acute Ischemic Stroke
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
St. Louis, MO
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) on Reducing Infarct Volume in Acute Ischemic Stroke
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) on Reducing Infarct Volume in Acute Ischemic Stroke
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
New York, NY
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) on Reducing Infarct Volume in Acute Ischemic Stroke
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) on Reducing Infarct Volume in Acute Ischemic Stroke
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Durham, NC
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) on Reducing Infarct Volume in Acute Ischemic Stroke
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) on Reducing Infarct Volume in Acute Ischemic Stroke
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Dayton, OH
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) on Reducing Infarct Volume in Acute Ischemic Stroke
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Dayton, OH
Click here to add this to my saved trials
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) on Reducing Infarct Volume in Acute Ischemic Stroke
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Portland, OR
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) on Reducing Infarct Volume in Acute Ischemic Stroke
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) on Reducing Infarct Volume in Acute Ischemic Stroke
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Tualatin, OR
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) on Reducing Infarct Volume in Acute Ischemic Stroke
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Tualatin, OR
Click here to add this to my saved trials
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) on Reducing Infarct Volume in Acute Ischemic Stroke
Status: Enrolling
Updated:  8/27/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) on Reducing Infarct Volume in Acute Ischemic Stroke
Status: Enrolling
Updated: 8/27/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) on Reducing Infarct Volume in Acute Ischemic Stroke
Status: Enrolling
Updated:  8/27/2015
Research Site
mi
from
Altenburg,
Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) on Reducing Infarct Volume in Acute Ischemic Stroke
Status: Enrolling
Updated: 8/27/2015
Research Site
mi
from
Altenburg,
Click here to add this to my saved trials
Proof of Principle for a Diagnostic Blood Test of Recurrent Seizures
Proof of Principle for a Diagnostic Blood Test of Recurrent Seizures
Status: Enrolling
Updated:  8/27/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Proof of Principle for a Diagnostic Blood Test of Recurrent Seizures
Proof of Principle for a Diagnostic Blood Test of Recurrent Seizures
Status: Enrolling
Updated: 8/27/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Comparison Between Different Types of Oxygen Treatment Following Traumatic Brain Injury
Hyperbaric and Normobaric Oxygen in Severe Brain Injury
Status: Enrolling
Updated:  8/27/2015
Hennepin County Medical Center
mi
from
Minneapolis, MN
Comparison Between Different Types of Oxygen Treatment Following Traumatic Brain Injury
Hyperbaric and Normobaric Oxygen in Severe Brain Injury
Status: Enrolling
Updated: 8/27/2015
Hennepin County Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Autoregulation Assessment During Liver Transplantation
Non-Invasive Assessment of Cerebral Blood Flow Autoregulation in Patients Undergoing Liver Transplantation
Status: Enrolling
Updated:  8/31/2015
Johns Hopkins Hospital
mi
from
Baltimore, MD
Autoregulation Assessment During Liver Transplantation
Non-Invasive Assessment of Cerebral Blood Flow Autoregulation in Patients Undergoing Liver Transplantation
Status: Enrolling
Updated: 8/31/2015
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Magnetic Resonance Imaging (MRI) in Amyotrophic Lateral Sclerosis (ALS)
Imaging Myelin Injury in Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  8/31/2015
Johns Hopkins University
mi
from
Baltimore, MD
Magnetic Resonance Imaging (MRI) in Amyotrophic Lateral Sclerosis (ALS)
Imaging Myelin Injury in Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 8/31/2015
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Umbilical Cord Blood Proteomic Analysis and Neonatal Brain Injury
Umbilical Cord Blood Proteomic Analysis and Neonatal Brain Injury
Status: Enrolling
Updated:  8/31/2015
Johns Hopkins Hospital
mi
from
Baltimore, MD
Umbilical Cord Blood Proteomic Analysis and Neonatal Brain Injury
Umbilical Cord Blood Proteomic Analysis and Neonatal Brain Injury
Status: Enrolling
Updated: 8/31/2015
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Internet Administration of the Modified Atkins Diet for Adults With Intractable Epilepsy
Internet Administration of the Modified Atkins Diet for Adults With Intractable Epilepsy
Status: Enrolling
Updated:  8/31/2015
Johns Hopkins Hospital
mi
from
Baltimore, MD
Internet Administration of the Modified Atkins Diet for Adults With Intractable Epilepsy
Internet Administration of the Modified Atkins Diet for Adults With Intractable Epilepsy
Status: Enrolling
Updated: 8/31/2015
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluation of Early Standardized Task-Specific Training (ESTT)
Evaluation of Early Standardized Task-Specific Training (ESTT) in Persons With Acute Stroke
Status: Enrolling
Updated:  9/1/2015
St. David's Rehabilitation Hospital
mi
from
Austin, TX
Evaluation of Early Standardized Task-Specific Training (ESTT)
Evaluation of Early Standardized Task-Specific Training (ESTT) in Persons With Acute Stroke
Status: Enrolling
Updated: 9/1/2015
St. David's Rehabilitation Hospital
mi
from
Austin, TX
Click here to add this to my saved trials
Evaluation of Early Standardized Task-Specific Training (ESTT)
Evaluation of Early Standardized Task-Specific Training (ESTT) in Persons With Acute Stroke
Status: Enrolling
Updated:  9/1/2015
Baylor Institute for Rehabilitation - Dallas
mi
from
Dallas, TX
Evaluation of Early Standardized Task-Specific Training (ESTT)
Evaluation of Early Standardized Task-Specific Training (ESTT) in Persons With Acute Stroke
Status: Enrolling
Updated: 9/1/2015
Baylor Institute for Rehabilitation - Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Evaluation of Early Standardized Task-Specific Training (ESTT)
Evaluation of Early Standardized Task-Specific Training (ESTT) in Persons With Acute Stroke
Status: Enrolling
Updated:  9/1/2015
Baylor Institute for Rehabilitation - Northwest
mi
from
Dallas, TX
Evaluation of Early Standardized Task-Specific Training (ESTT)
Evaluation of Early Standardized Task-Specific Training (ESTT) in Persons With Acute Stroke
Status: Enrolling
Updated: 9/1/2015
Baylor Institute for Rehabilitation - Northwest
mi
from
Dallas, TX
Click here to add this to my saved trials
Evaluation of Early Standardized Task-Specific Training (ESTT)
Evaluation of Early Standardized Task-Specific Training (ESTT) in Persons With Acute Stroke
Status: Enrolling
Updated:  9/1/2015
Baylor Institute for Rehabilitation - Frisco
mi
from
Frisco, TX
Evaluation of Early Standardized Task-Specific Training (ESTT)
Evaluation of Early Standardized Task-Specific Training (ESTT) in Persons With Acute Stroke
Status: Enrolling
Updated: 9/1/2015
Baylor Institute for Rehabilitation - Frisco
mi
from
Frisco, TX
Click here to add this to my saved trials
Examining the Effects of Video-game Exercise on Mobility and Brain Plasticity in Individuals With Multiple Sclerosis
Examining the Effects of Dance, Dance Revolution on Mobility, Brain Plasticity and Cognition in Individuals With Multiple Sclerosis
Status: Enrolling
Updated:  9/2/2015
The Ohio State University Atwell Hall
mi
from
Columbus, OH
Examining the Effects of Video-game Exercise on Mobility and Brain Plasticity in Individuals With Multiple Sclerosis
Examining the Effects of Dance, Dance Revolution on Mobility, Brain Plasticity and Cognition in Individuals With Multiple Sclerosis
Status: Enrolling
Updated: 9/2/2015
The Ohio State University Atwell Hall
mi
from
Columbus, OH
Click here to add this to my saved trials
Pediatric Seizure Movement Bed Alarm
Pediatric Seizure Alarm: A Pilot Study to Establish Efficacy Parameters
Status: Enrolling
Updated:  9/2/2015
LeBonheur Children's Medical Center
mi
from
Memphis, TN
Pediatric Seizure Movement Bed Alarm
Pediatric Seizure Alarm: A Pilot Study to Establish Efficacy Parameters
Status: Enrolling
Updated: 9/2/2015
LeBonheur Children's Medical Center
mi
from
Memphis, TN
Click here to add this to my saved trials
Development of Quality of Life Tool for TBI
Development of a Quality of Life Tool for Deployment Related TBI
Status: Enrolling
Updated:  9/3/2015
VA Palo Alto Health Care System
mi
from
Palo Alto, CA
Development of Quality of Life Tool for TBI
Development of a Quality of Life Tool for Deployment Related TBI
Status: Enrolling
Updated: 9/3/2015
VA Palo Alto Health Care System
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Development of Quality of Life Tool for TBI
Development of a Quality of Life Tool for Deployment Related TBI
Status: Enrolling
Updated:  9/3/2015
James A. Haley Veterans Hospital
mi
from
Tampa, FL
Development of Quality of Life Tool for TBI
Development of a Quality of Life Tool for Deployment Related TBI
Status: Enrolling
Updated: 9/3/2015
James A. Haley Veterans Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
Development of Quality of Life Tool for TBI
Development of a Quality of Life Tool for Deployment Related TBI
Status: Enrolling
Updated:  9/3/2015
VA Medical Center, Minneapolis
mi
from
Minneapolis, MN
Development of Quality of Life Tool for TBI
Development of a Quality of Life Tool for Deployment Related TBI
Status: Enrolling
Updated: 9/3/2015
VA Medical Center, Minneapolis
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Development of Quality of Life Tool for TBI
Development of a Quality of Life Tool for Deployment Related TBI
Status: Enrolling
Updated:  9/3/2015
Hunter Holmes McGuire VA Medical Center
mi
from
Richmond, VA
Development of Quality of Life Tool for TBI
Development of a Quality of Life Tool for Deployment Related TBI
Status: Enrolling
Updated: 9/3/2015
Hunter Holmes McGuire VA Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Acupuncture to Prevent Chemotherapy Dose Reduction Due to Chemotherapy-induced Peripheral Neuropathy in Breast and Colorectal Cancer Patients (GCC1232)
Acupuncture to Prevent Chemotherapy Dose Reduction Due to Chemotherapy-induced Peripheral Neuropathy in Breast and Colorectal Cancer Patients
Status: Enrolling
Updated:  9/3/2015
University of Maryland/Marlene and Stewart Greenebaum Cancer Center
mi
from
Baltimore, MD
Acupuncture to Prevent Chemotherapy Dose Reduction Due to Chemotherapy-induced Peripheral Neuropathy in Breast and Colorectal Cancer Patients (GCC1232)
Acupuncture to Prevent Chemotherapy Dose Reduction Due to Chemotherapy-induced Peripheral Neuropathy in Breast and Colorectal Cancer Patients
Status: Enrolling
Updated: 9/3/2015
University of Maryland/Marlene and Stewart Greenebaum Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Single-Dose Study of a New Formulation of BIIB061
A Single-Dose Study in Healthy Volunteers to Assess the Pharmacokinetic Profile of a New Formulation of BIIB061
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Madison, WI
Single-Dose Study of a New Formulation of BIIB061
A Single-Dose Study in Healthy Volunteers to Assess the Pharmacokinetic Profile of a New Formulation of BIIB061
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Dietary Interventions in Asthma Treatment: Sprouts Study
Dietary Interventions in Asthma Treatment: Sprouts Study
Status: Enrolling
Updated:  9/5/2015
Johns Hopkins University
mi
from
Baltimore, MD
Dietary Interventions in Asthma Treatment: Sprouts Study
Dietary Interventions in Asthma Treatment: Sprouts Study
Status: Enrolling
Updated: 9/5/2015
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Effects of Whole Sprouts on Upper Airway Allergic Inflammation
Dietary Interventions and Asthma Treatment: A Pilot Study of the Effects of Whole Sprouts on Upper Airway Allergic Inflammation
Status: Enrolling
Updated:  9/5/2015
Johns Hopkins Hospital
mi
from
Baltimore, MD
Effects of Whole Sprouts on Upper Airway Allergic Inflammation
Dietary Interventions and Asthma Treatment: A Pilot Study of the Effects of Whole Sprouts on Upper Airway Allergic Inflammation
Status: Enrolling
Updated: 9/5/2015
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Effects of Tolcapone on Frontotemporal Dementia
Investigation of the Dopamine System in Frontotemporal Dementia
Status: Enrolling
Updated:  9/8/2015
Columbia University Medical Center, 622 West 168th Street
mi
from
New York, NY
Effects of Tolcapone on Frontotemporal Dementia
Investigation of the Dopamine System in Frontotemporal Dementia
Status: Enrolling
Updated: 9/8/2015
Columbia University Medical Center, 622 West 168th Street
mi
from
New York, NY
Click here to add this to my saved trials
Very Intensive Early Walking in Stroke
Improving the Delivery of Intensive Gait Training in the Clinical Setting to Augment Community Ambulation
Status: Enrolling
Updated:  9/8/2015
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Very Intensive Early Walking in Stroke
Improving the Delivery of Intensive Gait Training in the Clinical Setting to Augment Community Ambulation
Status: Enrolling
Updated: 9/8/2015
Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated:  9/8/2015
Northwest NeuroSpecialists, PLLC
mi
from
Tucson, AZ
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status: Enrolling
Updated: 9/8/2015
Northwest NeuroSpecialists, PLLC
mi
from
Tucson, AZ
Click here to add this to my saved trials